世界のアテローム性動脈硬化症薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Atherosclerosis Drug Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3865 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、アテローム性動脈硬化症薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗血小板薬、コレステロール低下薬、フィブリン酸＆オメガ-3脂肪酸誘導体、その他）、用途別市場規模（小売薬局、病院薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・アテローム性動脈硬化症薬の市場動向 ・企業の競争状況、市場シェア ・アテローム性動脈硬化症薬の種類別市場規模と予測2016-2027（抗血小板薬、コレステロール低下薬、フィブリン酸＆オメガ-3脂肪酸誘導体、その他） ・アテローム性動脈硬化症薬の用途別市場規模と予測2016-2027（小売薬局、病院薬局、オンライン薬局） ・アテローム性動脈硬化症薬の北米市場規模2016-2027（アメリカ、カナダ） ・アテローム性動脈硬化症薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・アテローム性動脈硬化症薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・アテローム性動脈硬化症薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・アテローム性動脈硬化症薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（GlaxoSmithKline、Sanofi、F. Hoffmann-La Roche、Bayer、Novartis、Merck & Co、Janssen Pharmaceuticals、Mylan、Amgen Inc、Pfizer） ・結論

Market Analysis and Insights: Global Atherosclerosis Drug Market
The global Atherosclerosis Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Atherosclerosis Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Atherosclerosis Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Atherosclerosis Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Atherosclerosis Drug market.

Global Atherosclerosis Drug Scope and Market Size
Atherosclerosis Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Atherosclerosis Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Anti-platelet Medications
Cholesterol Lowering Medications
Fibric Acid and Omega-3 Fatty Acid Derivatives
Other

Segment by Application
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GlaxoSmithKline
Sanofi
F. Hoffmann-La Roche
Bayer
Novartis
Merck & Co
Janssen Pharmaceuticals
Mylan
Amgen Inc
Pfizer

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Atherosclerosis Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Anti-platelet Medications
1.2.3 Cholesterol Lowering Medications
1.2.4 Fibric Acid and Omega-3 Fatty Acid Derivatives
1.2.5 Other
1.3 Market by Application
1.3.1 Global Atherosclerosis Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Atherosclerosis Drug Market Perspective (2016-2027)
2.2 Atherosclerosis Drug Growth Trends by Regions
2.2.1 Atherosclerosis Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Atherosclerosis Drug Historic Market Share by Regions (2016-2021)
2.2.3 Atherosclerosis Drug Forecasted Market Size by Regions (2022-2027)
2.3 Atherosclerosis Drug Industry Dynamic
2.3.1 Atherosclerosis Drug Market Trends
2.3.2 Atherosclerosis Drug Market Drivers
2.3.3 Atherosclerosis Drug Market Challenges
2.3.4 Atherosclerosis Drug Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Atherosclerosis Drug Players by Revenue
3.1.1 Global Top Atherosclerosis Drug Players by Revenue (2016-2021)
3.1.2 Global Atherosclerosis Drug Revenue Market Share by Players (2016-2021)
3.2 Global Atherosclerosis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Atherosclerosis Drug Revenue
3.4 Global Atherosclerosis Drug Market Concentration Ratio
3.4.1 Global Atherosclerosis Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Atherosclerosis Drug Revenue in 2020
3.5 Atherosclerosis Drug Key Players Head office and Area Served
3.6 Key Players Atherosclerosis Drug Product Solution and Service
3.7 Date of Enter into Atherosclerosis Drug Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Atherosclerosis Drug Breakdown Data by Type
4.1 Global Atherosclerosis Drug Historic Market Size by Type (2016-2021)
4.2 Global Atherosclerosis Drug Forecasted Market Size by Type (2022-2027)

5 Atherosclerosis Drug Breakdown Data by Application
5.1 Global Atherosclerosis Drug Historic Market Size by Application (2016-2021)
5.2 Global Atherosclerosis Drug Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Atherosclerosis Drug Market Size (2016-2027)
6.2 North America Atherosclerosis Drug Market Size by Type
6.2.1 North America Atherosclerosis Drug Market Size by Type (2016-2021)
6.2.2 North America Atherosclerosis Drug Market Size by Type (2022-2027)
6.2.3 North America Atherosclerosis Drug Market Size by Type (2016-2027)
6.3 North America Atherosclerosis Drug Market Size by Application
6.3.1 North America Atherosclerosis Drug Market Size by Application (2016-2021)
6.3.2 North America Atherosclerosis Drug Market Size by Application (2022-2027)
6.3.3 North America Atherosclerosis Drug Market Size by Application (2016-2027)
6.4 North America Atherosclerosis Drug Market Size by Country
6.4.1 North America Atherosclerosis Drug Market Size by Country (2016-2021)
6.4.2 North America Atherosclerosis Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Atherosclerosis Drug Market Size (2016-2027)
7.2 Europe Atherosclerosis Drug Market Size by Type
7.2.1 Europe Atherosclerosis Drug Market Size by Type (2016-2021)
7.2.2 Europe Atherosclerosis Drug Market Size by Type (2022-2027)
7.2.3 Europe Atherosclerosis Drug Market Size by Type (2016-2027)
7.3 Europe Atherosclerosis Drug Market Size by Application
7.3.1 Europe Atherosclerosis Drug Market Size by Application (2016-2021)
7.3.2 Europe Atherosclerosis Drug Market Size by Application (2022-2027)
7.3.3 Europe Atherosclerosis Drug Market Size by Application (2016-2027)
7.4 Europe Atherosclerosis Drug Market Size by Country
7.4.1 Europe Atherosclerosis Drug Market Size by Country (2016-2021)
7.4.2 Europe Atherosclerosis Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Atherosclerosis Drug Market Size (2016-2027)
8.2 Asia-Pacific Atherosclerosis Drug Market Size by Type
8.2.1 Asia-Pacific Atherosclerosis Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Atherosclerosis Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Atherosclerosis Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Atherosclerosis Drug Market Size by Application
8.3.1 Asia-Pacific Atherosclerosis Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Atherosclerosis Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Atherosclerosis Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Atherosclerosis Drug Market Size by Region
8.4.1 Asia-Pacific Atherosclerosis Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Atherosclerosis Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Atherosclerosis Drug Market Size (2016-2027)
9.2 Latin America Atherosclerosis Drug Market Size by Type
9.2.1 Latin America Atherosclerosis Drug Market Size by Type (2016-2021)
9.2.2 Latin America Atherosclerosis Drug Market Size by Type (2022-2027)
9.2.3 Latin America Atherosclerosis Drug Market Size by Type (2016-2027)
9.3 Latin America Atherosclerosis Drug Market Size by Application
9.3.1 Latin America Atherosclerosis Drug Market Size by Application (2016-2021)
9.3.2 Latin America Atherosclerosis Drug Market Size by Application (2022-2027)
9.3.3 Latin America Atherosclerosis Drug Market Size by Application (2016-2027)
9.4 Latin America Atherosclerosis Drug Market Size by Country
9.4.1 Latin America Atherosclerosis Drug Market Size by Country (2016-2021)
9.4.2 Latin America Atherosclerosis Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Atherosclerosis Drug Market Size (2016-2027)
10.2 Middle East & Africa Atherosclerosis Drug Market Size by Type
10.2.1 Middle East & Africa Atherosclerosis Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Atherosclerosis Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Atherosclerosis Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Atherosclerosis Drug Market Size by Application
10.3.1 Middle East & Africa Atherosclerosis Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Atherosclerosis Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Atherosclerosis Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Atherosclerosis Drug Market Size by Country
10.4.1 Middle East & Africa Atherosclerosis Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Atherosclerosis Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Atherosclerosis Drug Introduction
11.1.4 GlaxoSmithKline Revenue in Atherosclerosis Drug Business (2016-2021)
11.1.5 GlaxoSmithKline Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Atherosclerosis Drug Introduction
11.2.4 Sanofi Revenue in Atherosclerosis Drug Business (2016-2021)
11.2.5 Sanofi Recent Development
11.3 F. Hoffmann-La Roche
11.3.1 F. Hoffmann-La Roche Company Details
11.3.2 F. Hoffmann-La Roche Business Overview
11.3.3 F. Hoffmann-La Roche Atherosclerosis Drug Introduction
11.3.4 F. Hoffmann-La Roche Revenue in Atherosclerosis Drug Business (2016-2021)
11.3.5 F. Hoffmann-La Roche Recent Development
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer Atherosclerosis Drug Introduction
11.4.4 Bayer Revenue in Atherosclerosis Drug Business (2016-2021)
11.4.5 Bayer Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Atherosclerosis Drug Introduction
11.5.4 Novartis Revenue in Atherosclerosis Drug Business (2016-2021)
11.5.5 Novartis Recent Development
11.6 Merck & Co
11.6.1 Merck & Co Company Details
11.6.2 Merck & Co Business Overview
11.6.3 Merck & Co Atherosclerosis Drug Introduction
11.6.4 Merck & Co Revenue in Atherosclerosis Drug Business (2016-2021)
11.6.5 Merck & Co Recent Development
11.7 Janssen Pharmaceuticals
11.7.1 Janssen Pharmaceuticals Company Details
11.7.2 Janssen Pharmaceuticals Business Overview
11.7.3 Janssen Pharmaceuticals Atherosclerosis Drug Introduction
11.7.4 Janssen Pharmaceuticals Revenue in Atherosclerosis Drug Business (2016-2021)
11.7.5 Janssen Pharmaceuticals Recent Development
11.8 Mylan
11.8.1 Mylan Company Details
11.8.2 Mylan Business Overview
11.8.3 Mylan Atherosclerosis Drug Introduction
11.8.4 Mylan Revenue in Atherosclerosis Drug Business (2016-2021)
11.8.5 Mylan Recent Development
11.9 Amgen Inc
11.9.1 Amgen Inc Company Details
11.9.2 Amgen Inc Business Overview
11.9.3 Amgen Inc Atherosclerosis Drug Introduction
11.9.4 Amgen Inc Revenue in Atherosclerosis Drug Business (2016-2021)
11.9.5 Amgen Inc Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Atherosclerosis Drug Introduction
11.10.4 Pfizer Revenue in Atherosclerosis Drug Business (2016-2021)
11.10.5 Pfizer Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Atherosclerosis Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Anti-platelet Medications
Table 3. Key Players of Cholesterol Lowering Medications
Table 4. Key Players of Fibric Acid and Omega-3 Fatty Acid Derivatives
Table 5. Key Players of Other
Table 6. Global Atherosclerosis Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Atherosclerosis Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Atherosclerosis Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Atherosclerosis Drug Market Share by Regions (2016-2021)
Table 10. Global Atherosclerosis Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Atherosclerosis Drug Market Share by Regions (2022-2027)
Table 12. Atherosclerosis Drug Market Trends
Table 13. Atherosclerosis Drug Market Drivers
Table 14. Atherosclerosis Drug Market Challenges
Table 15. Atherosclerosis Drug Market Restraints
Table 16. Global Atherosclerosis Drug Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Atherosclerosis Drug Market Share by Players (2016-2021)
Table 18. Global Top Atherosclerosis Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Atherosclerosis Drug as of 2020)
Table 19. Ranking of Global Top Atherosclerosis Drug Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Atherosclerosis Drug Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Atherosclerosis Drug Product Solution and Service
Table 23. Date of Enter into Atherosclerosis Drug Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Atherosclerosis Drug Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Atherosclerosis Drug Revenue Market Share by Type (2016-2021)
Table 27. Global Atherosclerosis Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Atherosclerosis Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Atherosclerosis Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Atherosclerosis Drug Revenue Market Share by Application (2016-2021)
Table 31. Global Atherosclerosis Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Atherosclerosis Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Atherosclerosis Drug Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Atherosclerosis Drug Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Atherosclerosis Drug Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Atherosclerosis Drug Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Atherosclerosis Drug Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Atherosclerosis Drug Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Atherosclerosis Drug Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Atherosclerosis Drug Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Atherosclerosis Drug Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Atherosclerosis Drug Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Atherosclerosis Drug Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Atherosclerosis Drug Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Atherosclerosis Drug Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Atherosclerosis Drug Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Atherosclerosis Drug Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Atherosclerosis Drug Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Atherosclerosis Drug Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Atherosclerosis Drug Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Atherosclerosis Drug Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Atherosclerosis Drug Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Atherosclerosis Drug Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Atherosclerosis Drug Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Atherosclerosis Drug Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Atherosclerosis Drug Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Atherosclerosis Drug Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Atherosclerosis Drug Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Atherosclerosis Drug Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Atherosclerosis Drug Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Atherosclerosis Drug Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Atherosclerosis Drug Market Size by Country (2022-2027) & (US$ Million)
Table 63. GlaxoSmithKline Company Details
Table 64. GlaxoSmithKline Business Overview
Table 65. GlaxoSmithKline Atherosclerosis Drug Product
Table 66. GlaxoSmithKline Revenue in Atherosclerosis Drug Business (2016-2021) & (US$ Million)
Table 67. GlaxoSmithKline Recent Development
Table 68. Sanofi Company Details
Table 69. Sanofi Business Overview
Table 70. Sanofi Atherosclerosis Drug Product
Table 71. Sanofi Revenue in Atherosclerosis Drug Business (2016-2021) & (US$ Million)
Table 72. Sanofi Recent Development
Table 73. F. Hoffmann-La Roche Company Details
Table 74. F. Hoffmann-La Roche Business Overview
Table 75. F. Hoffmann-La Roche Atherosclerosis Drug Product
Table 76. F. Hoffmann-La Roche Revenue in Atherosclerosis Drug Business (2016-2021) & (US$ Million)
Table 77. F. Hoffmann-La Roche Recent Development
Table 78. Bayer Company Details
Table 79. Bayer Business Overview
Table 80. Bayer Atherosclerosis Drug Product
Table 81. Bayer Revenue in Atherosclerosis Drug Business (2016-2021) & (US$ Million)
Table 82. Bayer Recent Development
Table 83. Novartis Company Details
Table 84. Novartis Business Overview
Table 85. Novartis Atherosclerosis Drug Product
Table 86. Novartis Revenue in Atherosclerosis Drug Business (2016-2021) & (US$ Million)
Table 87. Novartis Recent Development
Table 88. Merck & Co Company Details
Table 89. Merck & Co Business Overview
Table 90. Merck & Co Atherosclerosis Drug Product
Table 91. Merck & Co Revenue in Atherosclerosis Drug Business (2016-2021) & (US$ Million)
Table 92. Merck & Co Recent Development
Table 93. Janssen Pharmaceuticals Company Details
Table 94. Janssen Pharmaceuticals Business Overview
Table 95. Janssen Pharmaceuticals Atherosclerosis Drug Product
Table 96. Janssen Pharmaceuticals Revenue in Atherosclerosis Drug Business (2016-2021) & (US$ Million)
Table 97. Janssen Pharmaceuticals Recent Development
Table 98. Mylan Company Details
Table 99. Mylan Business Overview
Table 100. Mylan Revenue in Atherosclerosis Drug Business (2016-2021) & (US$ Million)
Table 101. Mylan Recent Development
Table 102. Amgen Inc Company Details
Table 103. Amgen Inc Business Overview
Table 104. Amgen Inc Atherosclerosis Drug Product
Table 105. Amgen Inc Revenue in Atherosclerosis Drug Business (2016-2021) & (US$ Million)
Table 106. Amgen Inc Recent Development
Table 107. Pfizer Company Details
Table 108. Pfizer Business Overview
Table 109. Pfizer Atherosclerosis Drug Product
Table 110. Pfizer Revenue in Atherosclerosis Drug Business (2016-2021) & (US$ Million)
Table 111. Pfizer Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Atherosclerosis Drug Market Share by Type: 2020 VS 2027
Figure 2. Anti-platelet Medications Features
Figure 3. Cholesterol Lowering Medications Features
Figure 4. Fibric Acid and Omega-3 Fatty Acid Derivatives Features
Figure 5. Other Features
Figure 6. Global Atherosclerosis Drug Market Share by Application: 2020 VS 2027
Figure 7. Retail Pharmacies Case Studies
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Atherosclerosis Drug Report Years Considered
Figure 11. Global Atherosclerosis Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Atherosclerosis Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Atherosclerosis Drug Market Share by Regions: 2020 VS 2027
Figure 14. Global Atherosclerosis Drug Market Share by Regions (2022-2027)
Figure 15. Global Atherosclerosis Drug Market Share by Players in 2020
Figure 16. Global Top Atherosclerosis Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Atherosclerosis Drug as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Atherosclerosis Drug Revenue in 2020
Figure 18. Global Atherosclerosis Drug Revenue Market Share by Type (2016-2021)
Figure 19. Global Atherosclerosis Drug Revenue Market Share by Type (2022-2027)
Figure 20. North America Atherosclerosis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Atherosclerosis Drug Market Share by Type (2016-2027)
Figure 22. North America Atherosclerosis Drug Market Share by Application (2016-2027)
Figure 23. North America Atherosclerosis Drug Market Share by Country (2016-2027)
Figure 24. United States Atherosclerosis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Atherosclerosis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Atherosclerosis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Atherosclerosis Drug Market Share by Type (2016-2027)
Figure 28. Europe Atherosclerosis Drug Market Share by Application (2016-2027)
Figure 29. Europe Atherosclerosis Drug Market Share by Country (2016-2027)
Figure 30. Germany Atherosclerosis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Atherosclerosis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Atherosclerosis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Atherosclerosis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Atherosclerosis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Atherosclerosis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Atherosclerosis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Atherosclerosis Drug Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Atherosclerosis Drug Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Atherosclerosis Drug Market Share by Region (2016-2027)
Figure 40. China Atherosclerosis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Atherosclerosis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Atherosclerosis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Atherosclerosis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Atherosclerosis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Atherosclerosis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Atherosclerosis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Atherosclerosis Drug Market Share by Type (2016-2027)
Figure 48. Latin America Atherosclerosis Drug Market Share by Application (2016-2027)
Figure 49. Latin America Atherosclerosis Drug Market Share by Country (2016-2027)
Figure 50. Mexico Atherosclerosis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Atherosclerosis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Atherosclerosis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Atherosclerosis Drug Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Atherosclerosis Drug Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Atherosclerosis Drug Market Share by Country (2016-2027)
Figure 56. Turkey Atherosclerosis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Atherosclerosis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Atherosclerosis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. GlaxoSmithKline Revenue Growth Rate in Atherosclerosis Drug Business (2016-2021)
Figure 60. Sanofi Revenue Growth Rate in Atherosclerosis Drug Business (2016-2021)
Figure 61. F. Hoffmann-La Roche Revenue Growth Rate in Atherosclerosis Drug Business (2016-2021)
Figure 62. Bayer Revenue Growth Rate in Atherosclerosis Drug Business (2016-2021)
Figure 63. Novartis Revenue Growth Rate in Atherosclerosis Drug Business (2016-2021)
Figure 64. Merck & Co Revenue Growth Rate in Atherosclerosis Drug Business (2016-2021)
Figure 65. Janssen Pharmaceuticals Revenue Growth Rate in Atherosclerosis Drug Business (2016-2021)
Figure 66. Mylan Revenue Growth Rate in Atherosclerosis Drug Business (2016-2021)
Figure 67. Amgen Inc Revenue Growth Rate in Atherosclerosis Drug Business (2016-2021)
Figure 68. Pfizer Revenue Growth Rate in Atherosclerosis Drug Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---